Bank Pictet & Cie (Europe)’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-12,897
| Closed | -$286K | – | 162 |
|
|
2024
Q1 | $286K | Sell |
12,897
-666
| -5% | -$14.8K | 0.01% | 149 |
|
|
2023
Q4 | $293K | Sell |
13,563
-516
| -4% | -$11.1K | 0.01% | 229 |
|
|
2023
Q3 | $238K | Buy |
14,079
+1,813
| +15% | +$30.6K | 0.01% | 238 |
|
|
2023
Q2 | $168K | Sell |
12,266
-474
| -4% | -$6.5K | 0.01% | 255 |
|
|
2023
Q1 | $289K | Buy |
12,740
+122
| +1% | +$2.77K | 0.01% | 153 |
|
|
2022
Q4 | $297K | Sell |
12,618
-3,339
| -21% | -$78.6K | 0.01% | 146 |
|
|
2022
Q3 | $416K | Buy |
+15,957
| New | +$416K | 0.02% | 125 |
|
|
2022
Q2 | – | Sell |
-10,724
| Closed | -$481K | – | 164 |
|
|
2022
Q1 | $481K | Buy |
10,724
+1,035
| +11% | +$46.4K | 0.02% | 127 |
|
|
2021
Q4 | $415K | Buy |
9,689
+1,065
| +12% | +$45.6K | 0.01% | 138 |
|
|
2021
Q3 | $574K | Sell |
8,624
-762
| -8% | -$50.7K | 0.02% | 125 |
|
|
2021
Q2 | $688K | Buy |
9,386
+1,266
| +16% | +$92.8K | 0.02% | 120 |
|
|
2021
Q1 | $556K | Buy |
+8,120
| New | +$556K | 0.02% | 122 |
|